<svelte:head>
    <title>Hereditary Alpha-Tryptasemia (HαT) | mastcell.help | mastcell.help</title>
</svelte:head>

<div class="prose">

<h1 id="hereditary-alpha-tryptasemia-hαt">Hereditary Alpha-Tryptasemia (HαT)</h1>
<p>Hereditary Alpha-Tryptasemia (HαT) is a genetic condition characterized by elevated levels of alpha-tryptase in the blood. Alpha-tryptase is a protein produced by mast cells, a type of white blood cell that plays a key role in the immune response, particularly in allergic and inflammatory reactions. Elevated alpha-tryptase levels are a hallmark of HαT and can be identified through blood tests.</p>
<p><strong>Key points</strong>:</p>
<ul>
<li><p><strong>Genetic Basis</strong>: HαT is caused by genetic variations in the TPSAB1 gene, which provides instructions for making alpha-tryptase. Specifically, individuals with HαT have extra copies of the TPSAB1 gene. While most people have two copies of this gene (one from each parent), individuals with HαT can have multiple copies, which results in elevated alpha-tryptase levels.</p></li>
<li><p><strong>Prevalence</strong>: HαT is considered a relatively common genetic condition, with an estimated prevalence in the general population of around 5-10%. It is more common in people with a family history of the condition.</p></li>
<li><p><strong>Symptoms</strong>: Many individuals with HαT are asymptomatic and do not experience any health problems related to their elevated alpha-tryptase levels. However, some individuals may experience symptoms such as unexplained fatigue, generalized pain, skin flushing, and gastrointestinal symptoms. These symptoms can be non-specific and may overlap with other medical conditions.</p></li>
<li><p><strong>Diagnosis</strong>: HαT is typically diagnosed through blood tests that measure alpha-tryptase levels. A diagnosis of HαT is made when an individual has elevated baseline alpha-tryptase levels on multiple occasions.</p></li>
<li><p><strong>Management</strong>: For individuals with HαT who are experiencing symptoms, management may involve addressing specific symptoms or underlying conditions. The management approach is individualized based on the person’s clinical presentation.</p></li>
<li><p><strong>Association with Other Conditions</strong>: HαT has been associated with an increased risk of mast cell activation syndrome (MCAS), which is a condition characterized by the inappropriate activation of mast cells and a wide range of symptoms. However, not all individuals with HαT will develop MCAS.</p></li>
<li><p><strong>Genetic Testing</strong>: Genetic testing for HαT typically involves analyzing the number of TPSAB1 gene copies to confirm the diagnosis. Genetic counseling may be recommended for individuals with HαT, particularly if they plan to have children, as the condition can be inherited.</p></li>
</ul>

</div>
